Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4

Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.
byBenzinga Newsdesk
February 14, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts